Patent Assignment
Reel/Frame 032513/0255
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF RECEIVING PARTY IN RELEASE OF PATENT SECURITY INTEREST IN EXCLUSIVELY LICENSED PATENTS PREVIOUSLY RECORDED ON REEL 032380 FRAME 0157. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST IN EXCLUSIVELY LICENSED PATENTS..
Recorded: 2014-03-24
Received: 2014-03-24
Pages: 17
Assignor
MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Executed: 2014-02-28
Assignee
ENDO PHARMACEUTICALS INC.
1400 ATWATER DRIVE, MALVERN, PA, 19355, UNITED STATES
Covered Applications
(40)
SELF-CALIBRATING SHARED-COMPONENT DUAL SYNTHESIZER
App. No. 14/137,366
→
METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITUS
App. No. 12/922,038
→
METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITIS
App. No. 12/515,429
→
AN ANTI-MISUSE MICROPARTICULATE ORAL PHARMACEUTICAL FORM
App. No. 12/638,739
→
ABUSE-PROOFED ORAL DOSAGE FORM
App. No. 12/140,470
→
ABUSE-PROOFED DOSAGE FORM
App. No. 12/140,444
→
PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED DOSAGE FORM
App. No. 12/140,609
→
ABUSE-PROOF DOSAGE FORM
App. No. 12/140,665
→
PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED SOLID DOSAGE FORM
App. No. 12/140,496
→
PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED DOSAGE FORM
App. No. 12/140,718
→
METHOD OF INHIBITING INFLAMMATORY PAIN
App. No. 11/774,816
→
Oral dosage form comprising an antimisuse system
App. No. 11/651,577
→
DOSAGE FORM THAT IS SAFEGUARDED FROM ABUSE
App. No. 10/567,594
→
ABUSE-PROOFED DOSAGE FORM
App. No. 11/462,216
→
Process for the production of an abuse-proofed dosage form
App. No. 11/471,438
→
Anti-misuse microparticulate oral pharmaceutical form
App. No. 11/439,432
→
Phosphate salts of 6-dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexane compounds
App. No. 11/361,954
→
Process for the production of an abuse-proofed dosage form
App. No. 11/348,276
→
Abuse-proofed dosage form
App. No. 11/349,537
→
ABUSE-PROOFED DOSAGE FORM
App. No. 11/349,544
→
Crush resistant delayed-release dosage forms
App. No. 11/348,295
→
Pharmaceutical composition containing 6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol with delayed active ingredient release
App. No. 11/334,344
→
COMBINATION OF SELECTED ANALGESICS AND COX-II INHIBITORS
App. No. 11/133,190
→
COMPOSITIONS AND METHODS FOR THE TREATMENT OF URINARY INCONTINENCE
App. No. 10/978,565
→
Process for the production of an abuse-proofed solid dosage form
App. No. 10/890,703
→
PROCESS FOR PRODUCTION OF AN ABUSE-PROOFED SOLID DOSAGE FORM
App. No. 10/890,704
→
Abuse-proofed oral dosage form
App. No. 10/890,763
→
Combination of selected opioids with muscarine antagonists for treating urinary incontinence
App. No. 10/803,187
→
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR RELIABLE ACHIEVEMENT OF ACCEPTABLE SERUM TESTOSTERONE LEVELS
App. No. 10/798,780
→
Abuse-proofed dosage form
App. No. 10/718,112
→
PENETRATION ENHANCING AND IRRITATION REDUCING SYSTEMS
App. No. 10/389,715
→
METHOD FOR THE ENZYMATIC RESOLUTION OF THE RACEMATES OF AMINOMETHYL-ARYL-CYCLOHEXANOL DERIVATIVES
App. No. 10/203,031
→
HYALURONIC ACID IN THE TREATMENT OF CANCER
App. No. 10/168,327
→
INTRADERMAL-PENETRATION AGENTS FOR TOPICAL LOCAL ANESTHETIC ADMINISTRATION
App. No. 10/201,901
→
COMPOSITION AND METHOD FOR INDUCING APOPTOSIS IN PROSTATE CANCER CELLS
App. No. 09/937,643
→
PENETRATION ENHANCING AND IRRITATION REDUCING SYSTEMS
App. No. 09/963,287
→
METHOD FOR THE TREATMENT OF INFLAMMATION
App. No. 09/857,333
→
CHEMOTHERAPEUTIC COMPOSITION AND METHOD
App. No. 09/857,332
→
SUSTAINED-RELEASE COMPOSITION INCLUDING AMORPHOUS POLYMER
App. No. 09/877,330
→
SYSTEM FOR OSMOTIC DELIVERY OF PHARMACEUTICALLY ACTIVE AGENTS
App. No. 09/872,173
→